ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. SOFTMAX Co's annualized net income for the quarter that ended in Dec. 2025 was 円0 Mil. SOFTMAX Co's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was 円3,790 Mil. Therefore, SOFTMAX Co's annualized ROE % for the quarter that ended in Dec. 2025 was 0.00%.
The historical rank and industry rank for SOFTMAX Co's ROE % or its related term are showing as below:
TSE:3671'
s ROE % Range Over the Past 10 Years
Min: 0.07 Med: 14.51 Max: 17.32
Current: 7.98
During the past 13 years, SOFTMAX Co's highest ROE % was 17.32%. The lowest was 0.07%. And the median was 14.51%.
TSE:3671's ROE % is ranked better than 56.98% of 623
companies
in the Healthcare Providers & Services industry
Industry Median: 5.86
vs TSE:3671: 7.98
SOFTMAX Co (TSE:3671) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
SOFTMAX Co ROE % Related Terms
SOFTMAX Co ROE % Historical Data
* Premium members only.
The historical data trend for SOFTMAX Co's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, SOFTMAX Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOFTMAX Co ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SOFTMAX Co's ROE % distribution charts can be found below:
* The bar in red indicates where SOFTMAX Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
SOFTMAX Co (TSE:3671) has a ROE % of 0.00% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on SOFTMAX Co and its competitors. Over the past decade, SOFTMAX Co's ROE % has ranged from 0.07 to 17.32. According to the industry distribution chart, SOFTMAX Co ranks #268 out of 623 companies in the Healthcare Providers & Services industry, placing it in the top 43%.
Is SOFTMAX Co's ROE % too high?
SOFTMAX Co's current ROE % is 0.00%. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 17.32. Based on the distribution chart, SOFTMAX Co ranks #268 out of 623 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, SOFTMAX Co has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOFTMAX Co's ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SOFTMAX Co ranks #268 out of 623 companies for ROE %. This puts SOFTMAX Co in the upper half of its industry. The industry median ROE % is 5.86. Historically, SOFTMAX Co's own ROE % has ranged from 0.07 to 17.32 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.86, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on SOFTMAX Co and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOFTMAX Co's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOFTMAX Co stock overvalued right now?
Based on GuruFocus' analysis, SOFTMAX Co (TSE:3671) is currently considered Modestly Overvalued. The stock's GF Value™ is 円281.78, compared to a current price of 円315.00 — trading 11.8% above its estimated fair value. The current ROE % is 0.00%. SOFTMAX Co's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For SOFTMAX Co (TSE:3671), the current ROE % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SOFTMAX Co (TSE:3671) Overvalued in 2026?
Based on GuruFocus' analysis, SOFTMAX Co stock appears to be overvalued.
The current stock price of 円315.00 is trading 11.8% above its estimated GF Value™ of 円281.78.
GuruFocus considers SOFTMAX Co to be Modestly Overvalued.
Key valuation signals for TSE:3671:
ROE %: 0.00%
GF Value™: 円281.78 vs. price of 円315.00 (11.8% above fair value)
No single metric tells the full story. See the TSE:3671 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SOFTMAX Co Ltd provides optimal solutions for customers based on their developed PlusUs series such as Web type electronic charts and medical accounting. It offers Web-type electronic medical record and ordering systems, health checkup systems, radiology department information systems, rehabilitation department systems, surgical department systems, hospital goods management systems, and nursing care management systems. Geographically it operates through the region of Japan.
70GF Score
Get the complete analysis for TSE:3671
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3671 has been successfully added to your 
